Mad Money

Cramer on Monday's market action: 'Too many buyers needed a reality check'

Key Points
  • "I think the people who bought the recovery stocks all last week and sold the Nasdaq were expecting much more rapid" vaccine progress and responded by dumping cruise line, airline, hotel and shopping mall stocks, CNBC's Jim Cramer said.
  • "In other words, it's not that the AstraZeneca results were disappointing, it's that too many buyers needed a reality check," the "Mad Money" host said. AstraZeneca released early stage vaccine trial data earlier Monday.
  • "Once they realized there was no miracle cure, the Covid-19 stocks came back with a vengeance," he said.
VIDEO4:2204:22
Cramer says the coronavirus stocks came back with a 'vengeance'

Wall Street's reaction to newly released data on a coronavirus vaccine candidate study revealed that the market lacks discipline, CNBC's Jim Cramer said Monday.

Researchers at Oxford University and AstraZeneca, one of the dozens of drugmakers racing to develop a potential Covid-19 vaccine, released positive results from their early stage human trial, but the good news did not lead to gains in the recovery plays, the "Mad Money" host noted.

"I think the people who bought the recovery stocks all last week and sold the Nasdaq were expecting much more rapid progress, so they threw a temper tantrum, dumping the cruise lines, dumping the airlines, dumping the hotels and dumping the shopping malls, then swapping into the tech stocks that profit from the pandemic," said Cramer, who earlier Monday blasted America's coronavirus response, calling it a "self-inflicted" disaster.

Despite the encouraging news from the phase one study by AstraZeneca and Oxford, the pandemic plays led the way as the market advanced in Monday's session. The Dow Jones inched up almost 9 points to 26,680.87. The S&P 500 advanced 0.84% to 3,251.84, and the tech-heavy Nasdaq surged 2.51% to 10,767.09.

The Cramer Covid-19 Index, which is made up of stocks that benefit from the stay-at-home environment, lifted 2.30%.

"In other words, it's not that the AstraZeneca results were disappointing, it's that too many buyers needed a reality check. Once they realized there was no miracle cure, the Covid-19 stocks came back with a vengeance," Cramer said.

"Remember that the Cramer Covid-19 Index — the ones that do better with Covid — represents close to half of the S&P, but more importantly, when you lump in the financials and health care ... you're talking about 70% of the market that either benefits from the pandemic or works either way," he added.

The FAANG stocks — Facebook, Amazon, Apple, Netflix and Google-parent Alphabet — climbed, as "confidence is crazy high for these big tech companies," Cramer said.

The cloud stocks of Zoom Video, RingCentral, Fortinet, Palo Alto Networks and others powering the remote work world are "almost old hat now," he said.

As for the investors who are concerned that the U.S. will enter another lockdown but betting that the government will dish out another round of stimulus funds, the stocks of Walmart, Dollar General, Target and Dollar Tree are worth playing, he said.

VIDEO8:0108:01
Cramer on Monday's session: 'Too many buyers needed a reality check'

Cramer's charitable trust owns shares of Facebook, Amazon, Apple and Alphabet.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com